Background: Over the past 20 years, research shows that families of people affected by severe mental illness (schizophrenia, bipolar disorder, and addiction) may suffer emotional distress and lack of self-esteem.
Aims: In this study, long-term effectiveness of a cognitive-behavioral treatment designed for relatives of people with severe mental illness was evaluated.
Method: A total of 30 relatives living with a person affected by a severe mental disorder received 10 sessions of tailored cognitive-behavioral therapy.
Results: The study shows that the treatment was effective for the reduction of depression-anxiety symptoms, as well as for negative emotions and psychological distress.
Conclusions: This psychological support program has shown to be effective as a treatment for the relatives of people with serious mental health problems both in the posttreatment and in the 12-month follow-up.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.7334/psicothema2015.172 | DOI Listing |
JMIR Form Res
January 2025
Mind-Body Medicine Lab, Department of Psychology and Neuroscience, Baylor University, Waco, TX, United States.
Background: Hypnotherapy has been shown to be a safe, nonhormonal intervention effective for treating menopausal hot flashes. However, women experiencing hot flashes may face accessibility barriers to in-person hypnotherapy. To solve this issue, a smartphone app has been created to deliver hypnotherapy.
View Article and Find Full Text PDFJ Nerv Ment Dis
January 2025
Faculty of Social and Behavioural Sciences, University of Amsterdam, Amsterdam, the Netherlands.
This study examined the relationship between change in symptom severity and personal recovery in patients with severe mental illness (SMI). Forty-nine outpatients at Mentrum/Arkin, Amsterdam, the Netherlands, were assessed at baseline and 3 years later, using the Brief Psychiatric Rating Scale and the Mental Health Recovery Measure. Correlation coefficients and linear regression analyses were used.
View Article and Find Full Text PDFJ Addict Med
December 2024
From the Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, British Columbia, Canada (PA, JSHW, JM, MN, VWL, MJI, NM); Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada (PA, MN, VWL, MJI, NM); Addictions and Concurrent Disorders Research Group, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada (JSHW, RMK); Substance Use Response and Facilitation Service, BC Children's Hospital, Provincial Health Services Authority, Vancouver, British Columbia, Canada (MJI); BC Mental Health & Substance Use Services, Provincial Health Services Authority, Vancouver, British Columbia, Canada (NM); Bridge, Public Health Institute, Oakland, CA (AAH); Department of Emergency Medicine, Highland General Hospital-Alameda Health System, Oakland, CA (AAH); Department of Emergency Medicine, University of California, San Francisco, CA (AAH); The C4 Foundation, Coronado, CA (RM); British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada (JSGM); Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada (JSGM); and Pharmacokinetics Modeling and Simulation Laboratory, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada (ARM).
Buprenorphine has superior safety in opioid use disorder compared with alternatives due to its action as a partial opioid agonist, which limits its ability to cause respiratory depression. There is a risk of precipitated opioid withdrawal after buprenorphine exposure in someone using full opioid agonists. Buprenorphine induction strategies that avoid precipitated withdrawal remain a crucial component for starting buprenorphine in individuals actively using opioids.
View Article and Find Full Text PDFPsychol Trauma
January 2025
Paul Baerwald School of Social Work and Social Welfare, Hebrew University of Jerusalem.
Objective: The Adult Scale/National Stressful Events Survey Short Scale (NSESSS) is an emerging brief screening measure for the severity of Acute Stress Symptoms based on the of acute stress disorder (ASD). Scant information is known about the NSESSS's psychometric properties among different cultures or populations exposed to an ongoing trauma and displacement. Therefore, the present study aimed to (a) assess for the first time the psychometric properties and construct validity of the Hebrew version of NSESSS in an internally displaced population following the massacre in Israel on October 7, 2023; and (b) assess the possible risk and protective predictors of ASD according to sociodemographic characteristics, types of trauma exposure, absence of basic needs, and social support.
View Article and Find Full Text PDFJ Consult Clin Psychol
January 2025
Department of Clinical Psychology and Psychotherapy, Osnabruck University.
Objective: The therapeutic alliance is one of the most stable predictors of symptom burden over the course of therapy. So far, this effect has only been examined on the basis of sessions. Continuous-time models (CTM) allow this relationship to be modeled as a continuous process in which the actual time interval between measurements is considered.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!